Introduction: Metastases account for approximately 2-5% of all malignant pancreatic tumors, with renal cell carcinoma (RCC) comprising nearly two-thirds of these cases. The role of surgical resection for RCC metastases to the pancreas remains controversial.
Sonntag et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: